Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Middle East Health Journal.
Press releases published on April 9, 2025
Burnout Rate Improving Among Physicians, Though Rates Remain High Since 2011
GlobeNewswire
·
April 9, 2025
CHICAGO, April 09, 2025 (GLOBE NEWSWIRE) -- The occupational burnout rate among physicians in the United States continues to moderate after skyrocketing to a record-high in 2021 during the COVID-19 pandemic, according to a newly published study in Mayo …
Prime Biome Reviews (ALERT): I TRIED IT, Tracked It, and Exposed the Good, Bad & Unexpected
GlobeNewswire
·
April 9, 2025
FORT LAUDERDALE, Fla., April 09, 2025 (GLOBE NEWSWIRE) -- Prime Biome Review I’ll be honest—I’ve tried more than my fair share of probiotics. From big-name capsules at chain stores to fancy gummies shipped from across the country, nothing ever truly …
CareSource completes acquisition of Commonwealth Care Alliance to strengthen care for Massachusetts residents with significant needs
GlobeNewswire
·
April 9, 2025
DAYTON, Ohio and BOSTON, April 09, 2025 (GLOBE NEWSWIRE) -- CareSource, a nationally recognized, nonprofit managed care organization, today completed the acquisition* of Commonwealth Care Alliance (CCA), a nonprofit, mission-driven health care services …
Merit Medical Launches the Ventrax™ Delivery System
GlobeNewswire
·
April 9, 2025
SOUTH JORDAN, Utah, April 09, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today announced the US commercial release of its Ventrax Delivery System. The new delivery system is Merit’s latest …
Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine
GlobeNewswire
·
April 9, 2025
Strategic Combination Intended to Drive Advanced AI-Driven Drug Development and Expand Precision Medicine Applications Across Cancer and Neurology LOS ANGELES, April 09, 2025 (GLOBE NEWSWIRE) -- Renovaro Biosciences Inc. (NASDAQ: RENB), a TechBio leader …
Better Choice Company Regains Compliance with NYSE American Continued Listing Standards
GlobeNewswire
·
April 9, 2025
TAMPA, Fla., April 09, 2025 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, today announced that it received formal notice from the NYSE American LLC (the “ …
PacBio Announces Preliminary First Quarter 2025 Revenue and Reiterates 2025 Revenue Guidance of $155 Million to $170 Million
GlobeNewswire
·
April 9, 2025
Implements Plan to Reduce Annualized Operating Expense Run Rate by $45 Million to $50 Million Q1 2025 Earnings Conference Call Scheduled for May 8, 2025 MENLO PARK, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced …
Methodist Healthcare Ministries Awards Texas A&M University School of Public Health $5 Million to Continue South Texas Safe Water Project
GlobeNewswire
·
April 9, 2025
San Antonio, TX, April 09, 2025 (GLOBE NEWSWIRE) -- Methodist Healthcare Ministries of South Texas, Inc. (MHM) announced it will continue partnering with the Texas A…
Privia Health Enters Arizona In Partnership with Integrated Medical Services
GlobeNewswire
·
April 9, 2025
IMS is One of the Largest Independent Multi-Specialty Practices in the State Arizona Represents 15th State in National Primary Care-Centric Care Delivery Network ARLINGTON, Va., April 09, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) …
Nextech to Launch New Med Spa Platform, Preview CRM at The Medical Spa Show
GlobeNewswire
·
April 9, 2025
Tampa, Fla., April 09, 2025 (GLOBE NEWSWIRE) -- Nextech, the leader in healthcare technology and practice management solutions for specialty providers, will launch a new med spa aesthetic platform and preview new customer relationship management (CRM) …
Imprivata Introduces New Advanced Analytics Solution to Deliver Key Security and Operational Insights into Enterprise Mobile Device Usage
GlobeNewswire
·
April 9, 2025
WALTHAM, Mass., April 09, 2025 (GLOBE NEWSWIRE) -- Imprivata®, the digital identity company for life- and mission-critical industries, today announced that Imprivata Mobile Access Management® now offers enhanced analytics capabilities to provide critical …
IM8 Vibrante Miami: Fueling Wellness and Innovation with a Star-Studded Event
GlobeNewswire
·
April 9, 2025
David Beckham was Joined by Dr. Amy Shah, Dr. Jeremy London, Dr. James DiNicolantonio and Kendal Toole to Reinforce IM8’s Vision for Elite Wellness Accessible to All CHARLOTTE, N.C., April 09, 2025 (GLOBE NEWSWIRE) -- On Monday, IM8, the premium supplement …
UAV Corp and Genetic Networks Announce Strategic Collaboration to Combat Biohazards with Cutting-Edge Technology, Genetic Networks Signs MOU with UMAV
GlobeNewswire
·
April 9, 2025
MELBOURNE, Fla., April 09, 2025 (GLOBE NEWSWIRE) -- via IBN - Fifty 1 Labs, Inc. (OTC: FITY), through its wholly owned subsidiary Genetic Networks, a pioneer in genetic perturbation and drug discovery, and UAV Corp (OTC: UMAV), a leader in unmanned aerial …
Oragenics, Inc. Announces Health and Disability Ethics Committee Submission for Phase IIa Concussion Trial
GlobeNewswire
·
April 9, 2025
SARASOTA, Fla., April 09, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company focused on developing novel intranasal therapies for brain-related conditions, today announced that it has submitted a clinical trial protocol …
Biomarkers Market Worth $93.8 billion | MarketsandMarkets™.
GlobeNewswire
·
April 9, 2025
Delray Beach, FL, April 09, 2025 (GLOBE NEWSWIRE) -- Biomarkers Market , valued at US$54.8 billion in 2023, is forecasted to grow at a robust CAGR of 10.2%, reaching US$57.7 billion in 2024 and an impressive US$93.8 billion by 2029 according to a published …
Microbot Medical® Shares Results from Its Pivotal Clinical Trial, Achieving 100% Robotic Navigation Success for the LIBERTY® Endovascular Robotic System
GlobeNewswire
·
April 9, 2025
Successful robotic navigation was achieved in every case and met the primary endpoint of the study LIBERTY® showed a 92% reduction in radiation exposure with no adverse events reported HINGHAM, Mass., April 09, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc …
Palisade Bio Completes Dosing in Phase 1a Portion of Ongoing Phase 1a/b Study of PALI-2108
GlobeNewswire
·
April 9, 2025
Sustained positive preliminary data from all completed single ascending dose (SAD) cohorts, multiple ascending dose (MAD) cohorts, and food effects crossover, further supporting the safety and tolerability of PALI-2108 No serious adverse events (SAEs) or …
Arialief Supplement: Vitamins Reviews and Complaints for Neuropathic Pain
GlobeNewswire
·
April 9, 2025
HONOLULU, April 09, 2025 (GLOBE NEWSWIRE) -- Arialief is a premium dietary supplement specifically designed to target the root causes of neuropathic discomfort. Whether your symptoms include burning, tingling, numbness, or stabbing nerve pain, Arialief …
M6P Therapeutics to Host Virtual KOL Event to Discuss the Lysosomal Storage Disorders Treatment Landscape on April 22, 2025
GlobeNewswire
·
April 9, 2025
ST. LOUIS, Mo., April 09, 2025 (GLOBE NEWSWIRE) -- M6P Therapeutics (“M6PT” or “the Company”), a privately held life sciences company developing next-generation enzyme replacement and gene therapies for lysosomal storage disorders (LSDs), today announced …
Cingulate Receives $3 Million Grant from Private Foundation to Accelerate Development of Anxiety Asset CTx-2103 (buspirone)
GlobeNewswire
·
April 9, 2025
CTx-2103 has the Potential to be the First, Once-Daily Formulation of Buspirone, one of the Most Widely Prescribed Agents in the $5.5 Billion U.S. Anxiety Market, and the $11.6 Billion Anxiety Market Worldwide Non-Dilutive Funding Expands Pipeline and …